Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremie Lebrec

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Neonatology|October 28, 2008
Impact of delayed arterial cord blood sampling for lactate assay: a prospective observational studyLionel Dessolle, Jeremie Lebrec, Emile Daraï
Fetal Diagnosis and Therapy|November 27, 2009
Arterial cord blood lactate at birth correlates with duration of pushing effortsLionel Dessolle, Jeremie Lebrec, Emile Daraï
Twin Research : the Official Journal of the International Society for Twin Studies|November 20, 2003
Selection strategies for linkage studies using twinsHein Putter, Jeremie Lebrec, Hans C van Houwelingen
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 28, 2019
GLP-1 RA Treatment and Dosing Patterns Among Type 2 Diabetes Patients in Six Countries: A Retrospective Analysis of Pharmacy Claims DataVictoria Divino, Kristina S Boye, Jeremie Lebrec, et al.
Journal of Alzheimer'S Disease : JAD|April 16, 2016
Describing the Sequence of Cognitive Decline in Alzheimer's Disease Patients: Results from an Observational StudyCarsten Henneges, Catherine Reed, Yun-Fei Chen, et al.
BMC Geriatrics|November 27, 2016
Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer's disease: 18-month UK results from the GERAS observational studyAlan Lenox-Smith, Catherine Reed, Jeremie Lebrec, et al.
Current Medical Research and Opinion|October 18, 2018
Utilization patterns of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus in Germany: a retrospective cohort studyThorsten Otto, Melissa Myland, Heike Jung, et al.
BMC Geriatrics|February 24, 2018
Potential cost savings to be made by slowing cognitive decline in mild Alzheimer's disease dementia using a model derived from the UK GERAS observational studyAlan Lenox-Smith, Catherine Reed, Jeremie Lebrec, et al.
Diabetes, Obesity & Metabolism|December 8, 2020
Treatment persistence in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists in clinical practice in SwedenAnn-Marie Svensson, Anders Toll, Jeremie Lebrec, et al.
Journal of Diabetes and Its Complications|March 30, 2020
Once-weekly dulaglutide versus insulin glargine in the early control of fasting serum glucose and HbA1cIrene Romera, Ignacio Conget, Luis Alberto Vazquez, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Neonatology|October 28, 2008
Impact of delayed arterial cord blood sampling for lactate assay: a prospective observational studyLionel Dessolle, Jeremie Lebrec, Emile Daraï
Fetal Diagnosis and Therapy|November 27, 2009
Arterial cord blood lactate at birth correlates with duration of pushing effortsLionel Dessolle, Jeremie Lebrec, Emile Daraï
Twin Research : the Official Journal of the International Society for Twin Studies|November 20, 2003
Selection strategies for linkage studies using twinsHein Putter, Jeremie Lebrec, Hans C van Houwelingen
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 28, 2019
GLP-1 RA Treatment and Dosing Patterns Among Type 2 Diabetes Patients in Six Countries: A Retrospective Analysis of Pharmacy Claims DataVictoria Divino, Kristina S Boye, Jeremie Lebrec, et al.
Journal of Alzheimer'S Disease : JAD|April 16, 2016
Describing the Sequence of Cognitive Decline in Alzheimer's Disease Patients: Results from an Observational StudyCarsten Henneges, Catherine Reed, Yun-Fei Chen, et al.
BMC Geriatrics|November 27, 2016
Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer's disease: 18-month UK results from the GERAS observational studyAlan Lenox-Smith, Catherine Reed, Jeremie Lebrec, et al.
Current Medical Research and Opinion|October 18, 2018
Utilization patterns of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus in Germany: a retrospective cohort studyThorsten Otto, Melissa Myland, Heike Jung, et al.
BMC Geriatrics|February 24, 2018
Potential cost savings to be made by slowing cognitive decline in mild Alzheimer's disease dementia using a model derived from the UK GERAS observational studyAlan Lenox-Smith, Catherine Reed, Jeremie Lebrec, et al.
Diabetes, Obesity & Metabolism|December 8, 2020
Treatment persistence in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonists in clinical practice in SwedenAnn-Marie Svensson, Anders Toll, Jeremie Lebrec, et al.
Journal of Diabetes and Its Complications|March 30, 2020
Once-weekly dulaglutide versus insulin glargine in the early control of fasting serum glucose and HbA1cIrene Romera, Ignacio Conget, Luis Alberto Vazquez, et al.
Pageof 3